Clinical trial

TC Avastin. ICORG 08-10, V6

NCT00911716

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-10-01

PhaseNA

Study timeline

Study start (unknown)2008-10-01Date precision: month

Registry last updated2019-08-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

bevacizumabBIOLOGICAL

cyclophosphamideDRUG · verified · RxNorm: cyclophosphamide

docetaxelDRUG · verified · RxNorm: docetaxel

adjuvant therapyPROCEDURE

Sponsors & collaborators

Cancer Trials Irelandlead sponsor

Mapped research locations

DublinIreland3

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00911716 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.